JPMorgan analyst Michael Newshel started The Advisory Board (ABCO) with an Overweight rating and $64 price target. A recent survey of hospital chief investment officers indicates there will be no slowdown in Healthcare Information Technology investments even as the electronic health records adoption cycle matures, Newshel tells investors in a research note. He also assumed lead coverage of athenahealth (ATHN) with an Overweight rating and $170 price target, Allscripts (MDRX) with an Overweight and $17 target, Connecture (CNXR) with a Neutral and $8 target, MedAssets (MDAS) with a Neutral and $31 target, and Quality Systems (QSII) with a Neutral and $15 target.